LifeSci Capital analyst Cory Jubinville initiated coverage of Mereo BioPharma (MREO) with an Outperform rating and $10 price target
LifeSci Capital analyst Cory Jubinville initiated coverage of Mereo BioPharma (MREO) with an Outperform rating and $10 price target